Why is $PHIO moving today? · SEC 8-K archive

$PHIO SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $PHIO: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $PHIO filing catalyst

Why did $PHIO trigger an AI stock catalyst alert?

$PHIO triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -3.5/10). Headline: Phio Pharmaceuticals Reports Q3 Loss of $0.36/Share, Cash Halves to $10.6M. Key points: - Q3 net loss widened to approximately $4.1M ($0.36 per share) vs $2.3M ($0.44 per share) in prior year period due to higher R&D expenses. - Cash and cash equivalents declined to $10.6M as of Sept 30, 2026, down from $21.0M at year-end 2025. - Company is advancing PH-762 into Phase 2b after completing cGMP manufacturing and submitting regulatory documents.

How did $PHIO stock react after the SEC filing?

After the SEC 8-K for $PHIO, observed market reaction: T0 price $0.80. Past moves do not guarantee future results.

Where can I get real-time $PHIO SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $PHIO via Telegram and the VIP Web Terminal from €10/month.

$PHIO

$PHIO – Phio Pharmaceuticals Reports Q3 Loss of $0.36/Share, Cash Halves to $10.6M

Phio Pharmaceuticals Corp.

2026-11-05 00:00:00 UTC · SEC 8-K · All $PHIO

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-3.5 / 10)

Q3 net loss widened to approximately $4.1M ($0.36 per share) vs $2.3M ($0.44 per share) in prior year period due to higher R&D expenses.
Cash and cash equivalents declined to $10.6M as of Sept 30, 2026, down from $21.0M at year-end 2025.
Company is advancing PH-762 into Phase 2b after completing cGMP manufacturing and submitting regulatory documents.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →